News
By Maia Hibbett, Wired | 09.09.2026
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola...
By Terence Keel, Los Ángeles Review of Books | 09.06.2026
This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...
By Stephanie O'Neill, The Madeleine Brand Show | 11.16.2011
Stem cell research is expensive. But advocates say it will one day yield cures that could save Americans billions in...
By Stephanie O'Neill, The Madeleine Brand Show | 11.16.2011
Stem cell research is expensive. But advocates say it will one day yield cures that could save Americans billions in...
By Pete Shanks
| 11.16.2011
Geron has quit on embryonic stem cells. The company is abandoning its world-leading clinical trial, aimed at using stem cells...
By Stephanie O'Neill, KPCC Southern California Public Radio | 11.16.2011
Stem cell therapies may one day provide cures for spinal chord injuries, heart damage and other serious medical conditions. For...
By Stephanie O'Neill, KPCC Southern California Public Radio | 11.16.2011
Stem cell therapies may one day provide cures for spinal chord injuries, heart damage and other serious medical conditions. For...
By Tony Kennedy, Star Tribune | 11.16.2011
The two-year-old case has pitted the genetic-privacy rights of families against science designed to advance public health and has put...
By Tony Kennedy, Star Tribune | 11.16.2011
The two-year-old case has pitted the genetic-privacy rights of families against science designed to advance public health and has put...
By Andrew Buncombe and Nina Lakhani, The Independent UK | 11.14.2011
Western pharmaceutical companies have seized on India over the past five years as a testing ground for drugs – making...